logo
Select company
Select metric
$ 221.68MOperating Expenses
VS
Market
48
Sector
31
Industry
22
History
80
$ 1.79Close
$ 0.67 - $ 1.82 52-Week Range
Ticker Information

Ticker

CHRS

Company Name

COHERUS ONCOLOGY INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

COHERUS ONCOLOGY INC - Operating Expenses Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CHRS - Op. Exp. Historical data
DateOperating Expenses
6/30/2025$ 221.68M
3/31/2025$ 226.45M
12/31/2024$ 261.07M
9/30/2024$ 274.4M
6/30/2024$ 291.86M
3/31/2024$ 303.15M
12/31/2023$ 301.45M
9/30/2023$ 308.23M
6/30/2023$ 325M
3/31/2023$ 349.48M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • COHERUS ONCOLOGY INC's latest trailing twelve months (TTM) Op. Exp. stands at $ 270.54M.
  • Over the past 5 years, COHERUS ONCOLOGY INC's average Op. Exp. has been $ 353.23M.
  • The median Op. Exp. for COHERUS ONCOLOGY INC during this period was $ 316.62M
  • COHERUS ONCOLOGY INC reached its highest Op. Exp. over the past 5 years at $ 532.82M.
  • The lowest Op. Exp. recorded by COHERUS ONCOLOGY INC in the same timeframe $ 221.68M

COHERUS ONCOLOGY INC's Op. Exp. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Op. Exp. Benchmarks
CompanyOp. Exp.
MGNX : MACROGENICS INC $ 221.86MIGMS : IGM BIOSCIENCES INC $ 206.93MSTRO : SUTRO BIOPHARMA INC $ 309.51MAGEN : AGENUS INC $ 192.51MATRA : ATARA BIOTHERAPEUTICS INC $ 145.24MCELU : CELULARITY INC $ 71.92MCSBR : CHAMPIONS ONCOLOGY INC $ 24.87MKPTI : KARYOPHARM THERAPEUTICS INC $ 247.49MIPSC : CENTURY THERAPEUTICS INC $ 146.69MIVVD : INVIVYD INC $ 156.68M

Definition of Operating Expenses

[Income Statement] Operating expenses are costs like [SGnA] and [RnD] incurred during regular operations. These costs can either be fixed or variable, and are dependend on the type of business. Common examples are rent, insurance, marketing, and payroll, it excludes cost of revenue [CoR].

CHRS - Operating Expenses, Last 5 years

$ 221.68M

Minimum

Jun 30, 2025

$ 532.82M

Maximum

Dec 31, 2021

$ 353.23M

Average

$ 316.62M

Median

Op. Exp. Benchmark Analysis

The chart above depicts the distribution of Op. Exp. for companies in the Total Stock Market. The average Op. Exp. of the companies is $ 232.5M with a standard deviation of $ 271.53M.
The following table provides additional summary stats:
Op. Exp. in the Market:
filtered constituents3.46K
min$ -391.56M
max$ 1.16B
average$ 232.5M
median$ 120.21M
std$ 271.53M